Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 4/2009

01-08-2009 | Research Article

Prescribing errors in patients with documented drug allergies: comparison of ICD-10 coding and written patient notes

Authors: Arwa Benkhaial, Jens Kaltschmidt, Elke Weisshaar, Thomas L. Diepgen, Walter E. Haefeli

Published in: International Journal of Clinical Pharmacy | Issue 4/2009

Login to get access

Abstract

Introduction: Allergies to drugs are a major cause for hospitalisation and inappropriate prescriptions to patients. However, allergies can be prevented if the patient’s history of drug allergy is known and coded. Objective of the study: Assessment of the value of the widely used ICD-10 codes for drug-allergies (e.g. Z88, L27) as triggers for decision support in an electronic prescription system and evaluation of the potential impact of such an alert system. We also evaluated the usefulness of manual drug allergy notes recorded in patients’ charts in the prevention of prescribing errors due to drug allergies. Setting: University hospital providing primary and tertiary care. Methods: Using Anatomical Therapeutic Chemical (ATC) classification codes we allocated to drug specifying ICD-10 codes (i.e. Z88) all drugs belonging to the same group of compounds or those known to induce cross-allergy. In a randomly selected cohort of 200 in-patients we then assessed documentation and coding of drug allergies and incident prescribing errors ignoring patients’ drug allergies. Results: Eighteen of the 200 patients had an allergy-related ICD code in the chart, 51 had a written note, and 13 had both. About 21% of patients with documented drug allergies were prescribed a drug potentially triggering the allergy. There was no difference in prescribing errors due to drugs potentially inducing allergies when the allergy was only documented as an ICD-10 code or the information was available in the paper record (P > 0.05). Conclusion: The findings of this study emphasise the necessity of a more precise and efficient documentation system of drug allergies along with the implementation of an electronic CDS for drug allergies that makes physicians aware of patients’ drug allergies during the prescribing process.
Literature
1.
go back to reference Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol. 2004;113:832–6. doi:10.1016/j.jaci.2003.12.591.CrossRefPubMed Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol. 2004;113:832–6. doi:10.​1016/​j.​jaci.​2003.​12.​591.CrossRefPubMed
6.
go back to reference Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol. 2003;90:342–7.CrossRefPubMed Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol. 2003;90:342–7.CrossRefPubMed
11.
12.
go back to reference Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma’Luf N, et al. The impact of computerised physician order entry on medication error prevention. J Am Med Inform Assoc. 1999;6:313–21.CrossRefPubMedPubMedCentral Bates DW, Teich JM, Lee J, Seger D, Kuperman GJ, Ma’Luf N, et al. The impact of computerised physician order entry on medication error prevention. J Am Med Inform Assoc. 1999;6:313–21.CrossRefPubMedPubMedCentral
13.
go back to reference Brunton LL, Lazo JS, editors. Goodman and Gilman’s: the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. ISBN: 0-07-142280-3. Brunton LL, Lazo JS, editors. Goodman and Gilman’s: the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2006. ISBN: 0-07-142280-3.
18.
go back to reference Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract. 2006;55:106–12.PubMed Pichichero ME. Cephalosporins can be prescribed safely for penicillin-allergic patients. J Fam Pract. 2006;55:106–12.PubMed
20.
go back to reference Prescott WA, DePestel DD, Ellis JJ, Regal RE. Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. Clin Infect Dis. 2004;38:1102–7. doi:10.1086/382880.CrossRefPubMed Prescott WA, DePestel DD, Ellis JJ, Regal RE. Incidence of carbapenem-associated allergic-type reactions among patients with versus patients without a reported penicillin allergy. Clin Infect Dis. 2004;38:1102–7. doi:10.​1086/​382880.CrossRefPubMed
24.
go back to reference Saxon A, Hassner A, Swabb EA, Wheeler B, Adkinson F Jr. Lack of cross-reactivity between aztreonam, a monobactam antibiotic, and penicillin in penicillin-allergic subjects. J Infect Dis. 1984;149:16–22.CrossRefPubMed Saxon A, Hassner A, Swabb EA, Wheeler B, Adkinson F Jr. Lack of cross-reactivity between aztreonam, a monobactam antibiotic, and penicillin in penicillin-allergic subjects. J Infect Dis. 1984;149:16–22.CrossRefPubMed
25.
go back to reference Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulphonamide antibiotics and sulphonamide nonantibiotics. N Engl J Med. 2003;349:1628–35. doi:10.1056/NEJMoa022963.CrossRefPubMed Strom BL, Schinnar R, Apter AJ, Margolis DJ, Lautenbach E, Hennessy S, et al. Absence of cross-reactivity between sulphonamide antibiotics and sulphonamide nonantibiotics. N Engl J Med. 2003;349:1628–35. doi:10.​1056/​NEJMoa022963.CrossRefPubMed
29.
go back to reference Wasserman MJ, Weber DA, Guthrie JA, Bykerk VP, Lee P, Keystone EC. Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number. J Rheumatol. 2004;31:1912–7.PubMed Wasserman MJ, Weber DA, Guthrie JA, Bykerk VP, Lee P, Keystone EC. Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number. J Rheumatol. 2004;31:1912–7.PubMed
31.
go back to reference Cantrill JA, Cottrell WN. Accuracy of drug allergy documentation. Am J Health Syst Pharm. 1997;54:1627–9.PubMed Cantrill JA, Cottrell WN. Accuracy of drug allergy documentation. Am J Health Syst Pharm. 1997;54:1627–9.PubMed
36.
go back to reference Wipple JK, Ausman RK, Quebbman EJ. Narcotic use in the hospital: reasonably safe? Ann Pharmacother. 1992;26:897–901.CrossRef Wipple JK, Ausman RK, Quebbman EJ. Narcotic use in the hospital: reasonably safe? Ann Pharmacother. 1992;26:897–901.CrossRef
37.
go back to reference Apter AJ, Kinman J, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, et al. Is there cross-reactivity between penicillins and cephalosporins? Am J Med. 2006;119:354.e11–20.CrossRef Apter AJ, Kinman J, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, et al. Is there cross-reactivity between penicillins and cephalosporins? Am J Med. 2006;119:354.e11–20.CrossRef
38.
go back to reference Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol. 1995;74:167–70.PubMed Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol. 1995;74:167–70.PubMed
39.
go back to reference Romano A, Guéant-Rodriguez RM, Viola M, Pettinato R, Guéant JL. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med. 2004;141:16–22.CrossRefPubMed Romano A, Guéant-Rodriguez RM, Viola M, Pettinato R, Guéant JL. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med. 2004;141:16–22.CrossRefPubMed
42.
go back to reference Quinzler R, Schmitt SPW, Szecsenyi J, Haefeli WE. Optimizing information on drug exposure by collection of package code information in questionnaire surveys. Pharmacoepidemiol Drug Saf. 2007;16:1024–30. doi:10.1002/pds.1406.CrossRefPubMed Quinzler R, Schmitt SPW, Szecsenyi J, Haefeli WE. Optimizing information on drug exposure by collection of package code information in questionnaire surveys. Pharmacoepidemiol Drug Saf. 2007;16:1024–30. doi:10.​1002/​pds.​1406.CrossRefPubMed
43.
go back to reference Adkinson NF Jr. Drug allergy. In: Adkinson NF Jr., Bochner BS, editors. Middleton’s allergy principles and practice. vol. II, 6th ed. Philadelphia: Mosby; 2003. pp. 1679–94. ISBN: 0-323-01425-9. Adkinson NF Jr. Drug allergy. In: Adkinson NF Jr., Bochner BS, editors. Middleton’s allergy principles and practice. vol. II, 6th ed. Philadelphia: Mosby; 2003. pp. 1679–94. ISBN: 0-323-01425-9.
44.
go back to reference Yates AB, deShazo RD. Drug allergies and hypersensitivity. In: Rich RR, Fleisher TA, editors. Clinical immunology: principles & practice. 2nd ed. London: Mosby; 2001. Pp. 54.1–15. ISBN: 0 7234 3161 2. Yates AB, deShazo RD. Drug allergies and hypersensitivity. In: Rich RR, Fleisher TA, editors. Clinical immunology: principles & practice. 2nd ed. London: Mosby; 2001. Pp. 54.1–15. ISBN: 0 7234 3161 2.
Metadata
Title
Prescribing errors in patients with documented drug allergies: comparison of ICD-10 coding and written patient notes
Authors
Arwa Benkhaial
Jens Kaltschmidt
Elke Weisshaar
Thomas L. Diepgen
Walter E. Haefeli
Publication date
01-08-2009
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 4/2009
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-009-9300-5

Other articles of this Issue 4/2009

International Journal of Clinical Pharmacy 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.